Translational control, whether it be mTOR or ISR regulation has been implicated in pro-survival mechanisms in a variety of diseases including cancer where targeting mTOR and PERK have been proposed as new generation therapeutic strategies in different contexts. The gene discussed is MTOR; the disease is cancer.